Ribavirin

Key facts

Invented name
Rebetol
Active substance
Ribavirin
Therapeutic area
Gastroentology-Hepatology
Decision number
P/63/2008
PIP number
Ribavirin
Pharmaceutical form(s)
Oral solution and Hard Capsules
Condition(s) / indication(s)
Chronic viral hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
The Netherlands
E-mail: pip.information@merck.com
Tel. +31 4126 63179
Fax +31 4126 62571
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-000070-PIP01-07
Compliance opinion date
17/10/2008
Compliance outcome
positive

Decision

How useful was this page?

Add your rating